Liver Disease
From the Journals
NASH rapidly overtaking hepatitis C as cause of liver cancer
The analysis is based on National Health and Nutrition Examination Survey and the Organ Procurement and Transplantation Network data.
News
ACIP unanimously recommends HEPLISAV-B
ACIP includes HEPLISAV-B as a recommended vaccine against hepatitis B in adults.
Feature
Liver cancer deaths expected to increase again in 2018
State estimates for this year put Utah and Hawaii at opposite ends of the mortality spectrum.
From the AGA Journals
Obesity affects the ability to diagnose liver fibrosis
As BMI increases, so does the discordance between liver imaging techniques.
News from the FDA/CDC
Psychiatric issues common among hepatitis C inpatients
Comorbidities like drug abuse and psychoses present much more often in those with hepatitis C.
Feature
Baby boomers are the hepatitis C generation
Adults born before and after the boomers have much lower rates of hepatitis C–related hospitalizations.
News
FDA adds boxed warning to obeticholic acid label
Data from required studies of the drug are expected in 2023.
Conference Coverage
Three in 10 diabetic patients may have liver fibrosis
Once there is a critical amount of triglycerides in the liver, some individuals are going to activate pathways that are harmful.
Conference Coverage
Isolated severe tricuspid regurgitation: An emerging disease
SNOWMASS, COLO. – “This is something different. ... It doesn’t fit into any of the textbook categories.”
From the Journals
Eradicating HCV significantly improved liver stiffness in meta-analysis
Liver stiffness decreased after patients achieved sustained virologic response.